Vectibix 20 mg/ml concentrate for solution for infusion, Stivarga 40 mg film-coated tablets clinical trials

Randomized phase II study of PAnitumumab REchallenge followed by REgorafenib versus the reverse sequence in RAS and BRAF wild-type chemorefractory metastatic colorectal cancer patients. The PARERE trial

This study looks at treating advanced bowel cancer that has spread, using two different medicines. We want to see if giving one medicine first then the other, or vice versa, helps people live longer and has fewer side effects. It's for people whose cancer has specific genetic markers.